✦ LIBER ✦

Comparison Between Nifedipine and Carvedilol in the Treatment of de novo Arterial Hypertension After Liver Transplantation: Preliminary Results of a Controlled Clinical Trial

✍ Scribed by A. Galioto; P. Angeli; S. Guarda; P. Burra; G. Zanus; S. Fasolato; S. Fagiuoli; A. Sticca; A. Semplicini; M. Sartori; A. Carraro; P. Boccagni; U. Cillo; A. Gatta

Book ID: 116930985
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 56 KB
Volume: 37
Category: Article
ISSN: 0041-1345
DOI: 10.1016/j.transproceed.2005.01.066

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nifedipine versus carvedilol in the trea

Nifedipine versus carvedilol in the treatment of de novo arterial hypertension after liver transplantation: Results of a controlled clinical trial

✍ Alessandra Galioto; Andrea Semplicini; Giacomo Zanus; Silvano Fasolato; Antoniet 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB 👁 1 views

The aim of this study was to compare nifedipine and carvedilol in the treatment of de novo arterial hypertension after orthotopic liver transplantation (OLT). The study included 50 patients who developed arterial hypertension after OLT. Twenty-five patients received nifedipine (group A), and 25 rece

33 Treatment of “de novo” arterial hyper

33 Treatment of “de novo” arterial hypertension after liver transplantation: A comparison between nifedipine and carvedilol

✍ A. Galioto; P. Angeli; R. Volpin; G. Serianni; S. Fasolato; L. Di Pascoli; S. Gu 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Comparison between two high-dose methylp

Comparison between two high-dose methylprednisolone schedules in the treatment of acute hepatic cellular rejection in liver transplant recipients: A controlled clinical trial

✍ Roberta Volpin; Paolo Angeli; Alessandra Galioto; Silvano Fasolato; Daniele Neri 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

Clinical and Angiographic Outcomes After

Clinical and Angiographic Outcomes After Treatment of De Novo Coronary Stenoses With a Novel Platinum Chromium Thin-Strut Stent: Primary Results of the PERSEUS (Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of the TAXUS Element Paclitaxel-Eluting Coronary Stent System) Trial

✍ Dean J. Kereiakes; Louis A. Cannon; Robert L. Feldman; Jeffrey J. Popma; Raymond 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 829 KB

Comparison of Everolimus-Eluting and Pac

Comparison of Everolimus-Eluting and Paclitaxel-Eluting Coronary Stents in Patients Undergoing Multilesion and Multivessel Intervention: The SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) and SPIRIT IV (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) Randomized Trials

✍ Dean J. Kereiakes; Krishnankutty Sudhir; James B. Hermiller; Paul C. Gordon; Joa 📂 Article 📅 2010 🏛 American College of Cardiology 🌐 English ⚖ 939 KB

ABSORB II randomized controlled trial: A

ABSORB II randomized controlled trial: A clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: Rationale and study design

✍ Roberto Diletti; Patrick W. Serruys; Vasim Farooq; Krishnankutty Sudhir; Cecile 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 419 KB